Fig. 8From: Co-administration of HAART and antikoch triggers cardiometabolic dysfunction through an oxidative stress-mediated pathwayEffects of antikoch and HAART on cardiac and plasma nitric oxide (NO) levels (A, B), myeloperoxidase (MPO) activities (C, D), and C-reactive protein (CRP) levels (E, F).Data are presented as mean ± SD of 8 replicates; *P < 0.05 vs control; #P < 0.05 vs antikoch; ~P < 0.05 vs HAARTBack to article page